They identified an association between mutated PALB2 and female breast cancer (RR = 7.18), male breast cancer (RR = 7.34), ovarian cancer (RR = 2.91), and pancreatic cancer (RR = 2.37). Here, PALB2 is linked to ovarian carcinoma.